Standout Papers

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated... 2013 2026 2017 2021 644
  1. PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies (2013)
    Benjamin J. Chen, Bjoern Chapuy et al. Clinical Cancer Research
  2. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome (2016)
    Margaretha G.M. Roemer, Ranjana H. Advani et al. Journal of Clinical Oncology
  3. Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma (2013)
    Bjoern Chapuy, Michael R. McKeown et al. Cancer Cell

Immediate Impact

2 by Nobel laureates 36 from Science/Nature 78 standout
Sub-graph 1 of 20

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Tertiary lymphoid structures in cancer
2022 StandoutScience
1 intermediate paper

Works of Heather H. Sun being referenced

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
2016 Standout
Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain
2014

Author Peers

Author Last Decade Papers Cites
Heather H. Sun 1550 1110 686 754 19 2.5k
Emma C. Scott 2247 898 644 1254 27 3.2k
David Bodkin 1312 1088 742 672 25 3.0k
Leonardo Flenghi 865 1449 533 975 35 2.7k
TP Miller 1982 1821 759 444 28 3.2k
Martin Gutierrez 2932 1198 631 1490 43 3.9k
P.M. Kluin 911 1211 486 482 37 2.2k
Marco Fizzotti 869 1362 341 460 37 2.0k
Harald Stein 1441 1855 930 1115 53 3.9k
T C Meeker 980 817 819 624 29 2.2k
D M Knowles 1004 1127 456 382 23 1.9k

All Works

Loading papers...

Rankless by CCL
2026